Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Antimicrob Agents Chemother
1999 Aug 01;438:2093-6. doi: 10.1128/AAC.43.8.2093.
Show Gene links
Show Anatomy links
In vitro activities of polycationic peptides alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
Giacometti A
,
Cirioni O
,
Ancarani F
,
Del Prete MS
,
Fortuna M
,
Scalise G
.
???displayArticle.abstract???
The in vitro activities of magainin II, nisin, and ranalexin alone and in combination with other antimicrobial agents against six clinical isolates of Rhodococcus equi were investigated by MIC and time-kill studies. All isolates were more susceptible to nisin. A positive interaction was observed when the peptides were combined with ampicillin, ceftriaxone, rifabutin, rifampin, azithromycin, clarithromycin, and vancomycin.
Bevins,
Peptides from frog skin.
1990,
Pubmed
,
Xenbase
Clark,
Ranalexin. A novel antimicrobial peptide from bullfrog (Rana catesbeiana) skin, structurally related to the bacterial antibiotic, polymyxin.
1994,
Pubmed
Emmons,
Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case.
1991,
Pubmed
Falla,
Improved activity of a synthetic indolicidin analog.
1997,
Pubmed
Hancock,
Antibacterial peptides and the outer membranes of gram-negative bacilli.
1997,
Pubmed
Harvey,
Rhodococcus equi infection in patients with and without human immunodeficiency virus infection.
1991,
Pubmed
Jack,
Bacteriocins of gram-positive bacteria.
1995,
Pubmed
Kunin,
Antimicrobial activity of rifabutin.
1996,
Pubmed
Moore,
Antimicrobial activity of cecropins.
1996,
Pubmed
Sahl,
Biosynthesis and biological activities of lantibiotics with unique post-translational modifications.
1995,
Pubmed
Sambatakou,
In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
1998,
Pubmed
Severina,
Antibacterial efficacy of nisin against multidrug-resistant Gram-positive pathogens.
1998,
Pubmed
Sirera,
Relapsing systemic infection due to Rhodococcus equi in a drug abuser seropositive for human immunodeficiency virus.
1991,
Pubmed
Vaara,
Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria.
1996,
Pubmed
Verville,
Rhodococcus equi infections of humans. 12 cases and a review of the literature.
1994,
Pubmed
Viljanen,
The outer membrane permeability-increasing action of deacylpolymyxins.
1991,
Pubmed
Zasloff,
Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor.
1987,
Pubmed
,
Xenbase
Zink,
Electron microscopic investigation of intracellular events after ingestion of Rhodococcus equi by foal alveolar macrophages.
1987,
Pubmed
